Anti-TNF therapy and juvenile idiopathic arthritis (JIA) Archives

Abstract Number: 2382 • ACR/ARHP Annual Meeting 2018
Real-World Safety and Effectiveness of Adalimumab in Patients with Juvenile Idiopathic Arthritis: Results from a Post-Marketing Surveillance in Japan
Syuji Takei¹, Naomi Iwata², Ichiro Kobayashi^3,4, Toru Igarashi⁵, Yoko Yoshinaga⁶, Naoko Matsubara⁷, Naomi Sunaga⁸, Ayumi Ito⁷ and Shumpei Yokota⁹, ¹Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan, ²Department of Immunology and Infectious Diseases, Aichi Children’s Health and Medical Center, Obu, Japan, ³Department of Allergy and Rheumatology, Chiba Children’s Hospital, Sapporo, Japan, ⁴Hokkaido University, Sapporo, Japan, ⁵Nippon Medical School, Tokyo, Japan, ⁶Evidence solution, Medical Communications, Medical, AbbVie GK, Tokyo, Japan, ⁷Medical, AbbVie GK, Tokyo, Japan, ⁸AbbVie GK, Tokyo, Japan, ⁹Fuji Toranomon Orthopedic Hospital, Gotemba, Japan
Background/Purpose: The safety and efficacy of adalimumab (an anti-TNF-α antibody) treatment in patients with JIA have been demonstrated in clinical trials. This study was conducted…
Abstract Number: 53 • Pediatric Rheumatology Symposium 2017
A Prospective Study to Assess for Changes in Mood with Initiation of Anti-TNF therapy: A Pilot Study
Kader Cetin Gedik¹, Helen Papaioannou², Monica Marcus³, Clifford Deutschman⁴ and Beth Gottlieb⁵, ¹Pediatric Rheumatology, Cohen Children's Medical Center fo New York, New Hyde Park, NY, ²Developmental and Behavioral Pediatrics, Cohen Children's Medical Center of New York, New Hyde Park, NY, ³Pediatric Immunology, Allergy and Rheumatology, Texas Children's Hospital, Houston, TX, ⁴Center for Pediatric Research, Cohen Chilredn's Medical Center of New York, New Hyde Park, NY, ⁵Pediatric Rheumatology, Cohen Children's Medical Center of New York, New Hyde Park, NY
Background/Purpose: Anti- tumor necrosis factor (anti-TNF) agents have been widely studied in the treatment of juvenile idiopathic arthritis (JIA) and inflammatory bowel disease (IBD). Although there…

Abstracts tagged "Anti-TNF therapy and juvenile idiopathic arthritis (JIA)"

Real-World Safety and Effectiveness of Adalimumab in Patients with Juvenile Idiopathic Arthritis: Results from a Post-Marketing Surveillance in Japan

A Prospective Study to Assess for Changes in Mood with Initiation of Anti-TNF therapy: A Pilot Study